Research Topics:
COVID-19
The SARS-CoV-2 pandemic has dramatically changed our lives and also our approach to doing research. In this respect, we actively engaged into several collaborations focusing on SARS-Cov2 protein characterization based on our expertise in protein production, biophysical and structural analyses.
Cartoon representation of the crystal structure of the complex between SARS-CoV-2 RBD and human ACE2 ectodomain. hACE2 is colored in wheat, SARS-CoV-2 RBD in magenta. Interface residues are shown with green and yellow sticks. |
Publications:
Efficient SARS-CoV-2 infection antagonization by rhACE2 ectodomain multimerized onto the avidin nucleic-acid-NanoASsembly
Biomaterials, 303, 122394. (2022) -
PubMed
Memory CD8+ T cell diversity and B cell responses correlate with protection against SARS-CoV-2 following mRNA vaccination
Nature Immunology, 23, 1445-1456. (2022) -
PubMed
Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care Workers
Journal of Clinical Medicine, 9, 3188. (2020) -
PubMed
A Pilot Study on Covid and Autism: Prevalence, Clinical Presentation and Vaccine Side Effects
Brain Sciences, 11, 860. (2021) -
PubMed
Epidemic Preparedness: Leishmania tarentolae as an Easy-to-Handle Tool to Produce Antigens for Viral Diagnosis: Application to COVID-19
Frontiers in Microbiology, 12, 736530. (2021) -
PubMed
SARS-CoV-2 Spike Affinity and Dynamics Exclude the Strict Requirement of an Intermediate Host
BioRxiv, (2021)
Active Grants related to this research: